This study evaluates imaging and blood and pancreatic fluid samples from patients who have high risk pancreatic cancer.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT06151223.
Locations matching your search criteria
United States
Minnesota
Rochester
Mayo Clinic in RochesterStatus: Active
Contact: Shounak Majumder
Phone: 507-266-6931
PRIMARY OBJECTIVES:
I. To facilitate discovery and validation of tests for early detection in subjects at high risk for pancreatic ductal adenocarcinoma (PDAC).
II. To facilitate the use of state-of-the-art machine learning algorithms that utilize databases and images with the purpose of identifying early stages of pancreatic cancer, as well as people at high-risk.
III. Provide a platform for development of an interventional protocol for early detection of PDAC.
OUTLINE: This is an observational study.
Participants undergo blood sample collection, complete surveys and have their medical records reviewed on study.
Trial PhaseNo phase specified
Trial Typescreening
Lead OrganizationMayo Clinic in Rochester
Principal InvestigatorShounak Majumder
